SAMHD1 and breast cancer: SAMHD1 expression varied significantly across tumor types, ranging from high percentage of positivity in rectal to low expression in pancreatic tumors, whereas values of 50–60% positivity were obtained for ovarian, NSCLC and breast cancer cases (Table 2).